Clorox (CLX) to Release Earnings on Monday

Clorox (NYSE:CLX) will likely be issuing its quarterly earnings data after the market closes on Monday, February 3rd. Analysts expect the company to announce earnings of $1.39 per share and revenue of $1.63 billion for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the company earned $0.49 EPS. The firm’s quarterly revenue was up 27.0% on a year-over-year basis. On average, analysts expect Clorox to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Clorox Trading Down 1.2 %

Shares of NYSE CLX opened at $158.60 on Friday. Clorox has a 1-year low of $127.60 and a 1-year high of $171.37. The company has a 50-day moving average of $162.98 and a two-hundred day moving average of $158.03. The company has a market cap of $19.63 billion, a PE ratio of 55.26, a P/E/G ratio of 2.91 and a beta of 0.42. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a yield of 3.08%. Clorox’s dividend payout ratio is currently 170.04%.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the stock. Barclays lowered their price target on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a research report on Friday, January 17th. DA Davidson increased their price target on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and lifted their price objective for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Evercore ISI dropped their price objective on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Finally, Wells Fargo & Company upgraded Clorox from an “underweight” rating to an “equal weight” rating and raised their target price for the stock from $155.00 to $157.00 in a report on Tuesday, January 7th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $156.07.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.